or Try an Advanced Search...

    Treatment Of Cancer Stocks List

    Symbol Grade Name % Change
    LIXT B Lixte Biotechnology Holdings, Inc. 0.07
    EXEL B Exelixis, Inc. 0.89
    TGTX B TG Therapeutics, Inc. 3.40
    CCM C Concord Medical Services Holdings Limited ADS -8.29
    HOWL C Werewolf Therapeutics, Inc. 1.00
    ONCY C Oncolytics Biotech Inc. 4.46
    IMTX C Immatics N.V. 0.74
    CLDX C Celldex Therapeutics, Inc. 3.84
    CGEN C Compugen Ltd. 8.54
    ONCT D Oncternal Therapeutics, Inc. 6.00
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Care Medical Instruments & Supplies Scientific & Technical Instruments Shell Companies
    Related Stock Lists: Cancer Biopharmaceutical Biotechnology Clinical Development Medicine Monoclonal Antibody Life Sciences Monoclonal Antibodies Solid Tumors Antibody Drug Conjugate Biomarkers Cancer Center Cancer Treatment Clinical Medicine Hematologic Cancers Immune System Immunology Immunotherapy Lymphoma Pharmaceutical Products

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Cancer stocks.

    Symbol Grade Name Weight
    IWC C iShares Microcap ETF 0.03
    AVSC C Avantis U.S. Small Cap Equity ETF 0.02
    DFAU C Dimensional US Core Equity Market ETF 0.0
    DFAC C Dimensional U.S. Core Equity 2 ETF 0.0
    DFAS C Dimensional U.S. Small Cap ETF 0.0
    View all Treatment Of Cancer ETFs...
    Compare ETFs
    Compare AVSC to DFAU Compare DFAC to DFAS Compare DFAU to DFAS

        Treatment Of Cancer Stocks Recent News

        Date Stock Title
        May 2 ONCT Oncternal Therapeutics to Provide Business Update and Report First Quarter 2024 Financial Results
        May 2 EXEL Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript
        May 2 EXEL Exelixis: With Patent Litigation Decision Due Soon, There Are Options
        May 2 EXEL Exelixis, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
        May 2 TGTX TG Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        May 2 TGTX TG Therapeutics Inc (TGTX) (Q1 2024) Earnings Call Transcript Highlights: Robust Revenue Growth ...
        May 2 TGTX Q1 2024 TG Therapeutics Inc Earnings Call
        May 1 TGTX TG Therapeutics jumps as Q1 Briumvi sales top guidance
        May 1 EXEL Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short
        May 1 TGTX TG Therapeutics Inc (TGTX) Surpasses Revenue Estimates in Q1 2024, Despite Widening Net Loss
        May 1 TGTX TG Therapeutics (TGTX) Reports Q1 Loss, Tops Revenue Estimates
        May 1 EXEL Q1 2024 Exelixis Inc Earnings Call
        May 1 TGTX TG Therapeutics GAAP EPS of -$0.07 misses by $0.03, revenue of $63.47M beats by $8.86M
        May 1 TGTX TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
        May 1 EXEL Exelixis Inc (EXEL) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
        May 1 EXEL Exelixis (EXEL) Q1 2024 Earnings Call Transcript
        May 1 EXEL Exelixis, Inc. (EXEL) Q1 2024 Earnings Call Transcript
        Apr 30 EXEL Exelixis down 7% as Q1 financial results disappoint
        Apr 30 EXEL Exelixis (EXEL) Reports Q1 Earnings: What Key Metrics Have to Say
        Apr 30 EXEL Exelixis Inc (EXEL) Q1 2024 Earnings: Mixed Results Amidst Restructuring Efforts
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Care Medical Instruments & Supplies Scientific & Technical Instruments Shell Companies
        Related Stock Lists: Advanced Solid Tumors Biopharmaceutical Biotechnology Cancer Cancer Immunotherapy Health Sciences Hematologic Malignancies Life Sciences Lymphoma Metastatic Solid Tumors Solid Tumors
        Treatment Of Cancer

        Treatment of cancer depends on the type and stage of the cancer, as well as the patient's overall health and preferences. Treatment options may include surgery, radiation therapy, chemotherapy, immunotherapy, targeted therapy, and/or hormone therapy. In some cases, a combination of treatments may be used.

        Browse All Tags